SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010615
Filing Date
2019-11-08
Accepted
2019-11-08 16:43:50
Documents
84
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q neos-20190930x10q.htm 10-Q 2946001
2 EX-31.1 neos-20190930ex31171e44e.htm EX-31.1 15073
3 EX-31.2 neos-20190930ex312092f7d.htm EX-31.2 15563
4 EX-32.1 neos-20190930ex3212c866f.htm EX-32.1 10281
  Complete submission text file 0001558370-19-010615.txt   10609031

Data Files

Seq Description Document Type Size
5 EX-101.INS neos-20190930.xml EX-101.INS 2129992
6 EX-101.SCH neos-20190930.xsd EX-101.SCH 74853
7 EX-101.CAL neos-20190930_cal.xml EX-101.CAL 77818
8 EX-101.DEF neos-20190930_def.xml EX-101.DEF 319302
9 EX-101.LAB neos-20190930_lab.xml EX-101.LAB 720834
10 EX-101.PRE neos-20190930_pre.xml EX-101.PRE 563202
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 191204623
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences